Hepatitis E natural history: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatitis E}} | {{Hepatitis E}} | ||
{{CMG}}; {{ | {{CMG}}; {{AE}} {{JS}} | ||
==Overview== | |||
==Natural History== | ==Natural History== | ||
==Complications== | ==Complications== | ||
| Line 13: | Line 12: | ||
==Prognosis== | ==Prognosis== | ||
In most immunocompetent patients hepatitis E is self-limited most of the times, thereby having a good prognosis. Immunocompromised patients, and those with end-stage liver disease are at higher risk of developing chronic hepatitis and other complications. These patients have a poor prognosis. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 24: | Line 21: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
Revision as of 20:08, 25 August 2014
|
Hepatitis E Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Hepatitis E natural history On the Web |
|
American Roentgen Ray Society Images of Hepatitis E natural history |
|
Risk calculators and risk factors for Hepatitis E natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Natural History
Complications
Prognosis
In most immunocompetent patients hepatitis E is self-limited most of the times, thereby having a good prognosis. Immunocompromised patients, and those with end-stage liver disease are at higher risk of developing chronic hepatitis and other complications. These patients have a poor prognosis.